Clinical Trial Update: Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the safety and efficacy of Sovateltide in patients with acute ischemic stroke is currently recruiting. The sponsor is Pharmazz, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Sovateltide (sovateltide)

Snippet

Sponsor: Pharmazz, Inc. | Conditions: Acute Ischemic Stroke, Cerebral Stroke | Phase 3 | Status: RECRUITING